查看原文
其他

我们团队的精准医学之路

2016-05-23 中国临床肿瘤 SIBCS



  临床研究优化了治疗方案,推动了治疗指南的制定和修改,带来了新的医学策略的思考。随着近年来个体化诊断及治疗手段的发展,乳腺癌治疗决策已步入了精准医学的新时代。


  2016年5月18日,《中国临床肿瘤》在线发表军事医学科学院附属医院(许凤锐、江泽飞)和北京清华长庚医院(王晓迪)的述评:我们团队的精准医学之路。











Chin Clin Oncol. 2016 May 18. [Epub ahead of print]


The way to precision medicine of our team.


Xu F, Wang X, Jiang Z.


Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China; Beijing Tsinghua Changgung Hospital, Beijing 102218, China.


In the past few years, the treatment model of breast cancer (BC) has undergone a variety of changes and the change of eras. Whether the classification treatment which is currently dominant, or the precision medicine which is extremely promising in the future are both carrying out the concept of individual treatment. Through retrospect the research and clinical achievement of our team in the past three decades, we share our experience and exertion on the exploration of a road to BC precision medicine in this paper and make a prospect of the future development direction of research and treatment.


KEYWORDS: Breast cancer (BC); liquid biopsies; precision medicine


PMID: 27197515


PII: cco.2016.05.03


DOI: 10.21037/cco.2016.05.03

您可能也对以下帖子感兴趣

文章有问题?点此查看未经处理的缓存